PASCALE, Rosa Maria
 Distribuzione geografica
Continente #
NA - Nord America 3.308
EU - Europa 1.995
AS - Asia 1.040
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 13
SA - Sud America 3
Totale 6.373
Nazione #
US - Stati Uniti d'America 3.291
UA - Ucraina 810
CN - Cina 802
DE - Germania 288
SE - Svezia 285
IT - Italia 204
FI - Finlandia 114
FR - Francia 113
TR - Turchia 80
SG - Singapore 76
GB - Regno Unito 69
CZ - Repubblica Ceca 49
BE - Belgio 33
IR - Iran 18
IN - India 17
CA - Canada 16
ID - Indonesia 16
KR - Corea 16
AU - Australia 13
EU - Europa 11
RO - Romania 6
AT - Austria 3
BD - Bangladesh 3
CH - Svizzera 3
EE - Estonia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
ES - Italia 2
IQ - Iraq 2
JP - Giappone 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BR - Brasile 1
CO - Colombia 1
DK - Danimarca 1
HK - Hong Kong 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
LU - Lussemburgo 1
LV - Lettonia 1
MM - Myanmar 1
MT - Malta 1
NL - Olanda 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PL - Polonia 1
SI - Slovenia 1
Totale 6.373
Città #
Chandler 955
Jacksonville 488
Princeton 272
Dearborn 200
Nanjing 198
Ann Arbor 165
Wilmington 137
Sassari 127
Nanchang 101
Boardman 87
Izmir 74
Beijing 72
Woodbridge 53
Changsha 52
Shenyang 51
Tianjin 48
Singapore 46
Brno 45
Hebei 38
Jinan 37
Brussels 33
Jiaxing 32
Norwalk 30
Falls Church 29
Ashburn 27
Zhengzhou 26
Ningbo 24
Hangzhou 22
Mountain View 22
Andover 19
Guangzhou 19
Augusta 17
Kunming 17
San Mateo 17
Leawood 16
Seoul 15
Ardabil 14
New York 13
Taizhou 13
Monmouth Junction 12
Toronto 12
San Francisco 10
Lanzhou 9
Los Angeles 9
Changchun 8
Melbourne 8
Munich 8
Cagliari 7
Hefei 7
Tappahannock 7
Messina 5
Auburn Hills 4
Berlin 4
Haikou 4
Olomouc 4
San Jose 4
Canberra 3
Chicago 3
Edinburgh 3
Grézieu-la-varenne 3
Mumbai 3
Perugia 3
Shanghai 3
Tallinn 3
Torino 3
Vienna 3
Washington 3
Alghero 2
Almè 2
Beinasco 2
Cedar Knolls 2
Città Di Castello 2
Cortoghiana 2
Fuzhou 2
Helsinki 2
Houston 2
Orange 2
Pompei 2
Redwood City 2
Rome 2
Sogliano al Rubicone 2
Stockholm 2
Wuppertal 2
Adliswil 1
Baghdad 1
Bogotá 1
Bridlington 1
Brierley Hill 1
Büdelsdorf 1
Central 1
Chalfont 1
Chengdu 1
Chittagong 1
Chongqing 1
Cupertino 1
Dallas 1
Dhaka 1
Dubai 1
Dublin 1
Haifa 1
Totale 3.855
Nome #
1-5-formyltetrahydrofolate and 1-5-methyltetrahydrofolate rescue in L-1210 leukemia treated with high methotrexate doses 85
Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-kappa B and Mat1A genes in the early stages of rat liver carcinogenesis 82
New insights on the role of epigenetic alterations in hepatocellular carcinoma 81
Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain 79
Role of HSP90,CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer 76
Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells 70
Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans 69
Alterations of methionine metabolism in hepatocarcinogenesis: the emergent role of glycine N-methyltransferase in liver injury 66
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 65
Analysis of loss of heterozygosity in neoplastic nodules induced by diethylnitrosomine in the resistant BFF1 rat strain 64
Chemoprevention of hepatocarcinogenesis: S.adenosyl-L-methionine 64
Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease 63
Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans 63
Experimental models to define the genetic predisposition to liver cancer 63
Decreased stimulation by 12-O-tetradecanoylphorbol-13-acetate of superoxide radical production by polymorphonuclear leukocytes carrying the Mediterranean variant of glucose-6-phosphate dehydrogenase. 62
Deregulation of methionine metabolism as determinant of progression and prognosis of hepatocellular carcinoma 62
Control of glucose-6-phosphate dehydrogenase deficiency on the formation of mutagenic and carcinogenic metabolites derived from benzo(a)pyrene. 61
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis 60
S-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers 60
Dependence of benzo(a)pyrene metabolism on NADPH pool in normal and glucose-6-phosphate dehydrogenase deficient human fibroblasts. 59
MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting MAT2A and MAT2B genes 59
Inhibition of promotion and persistent nodule growth by S-adenosyl-L-methionine in rat liver carcinogenesis: role of remodeling and apoptosis 58
5' Methylthioadenosine administration prevents lipid peroxidation and fibrogenesis induced in rat liver by carbon tetrachloride intoxication 58
Role of phosphatidylethanolamine methylation in the synthesis of phosphatidylcholine by hepatocytes isolated from choline-deficient rats. 57
Modulatory effect of glucose-6-phosphate dehydrogenase deficiency on benzo(a)pyrene toxicity and transforming activity for in vitro-cultured human skin fibroblasts. 57
Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans 57
Effect of S-adenosyl-L-methionine on the development of preneoplastic foci and the activity of some carbohydrate metabolizing enzymes in the liver, during experimental hepatocarcinogenesis. 57
Identification of genetic loci controlling hepatocarcinogenesis on rat chromosomes 7 and 10 56
Implication of Bcl 2 family genes in basal and D amphetamine induced apoptosis in preneoplastic and neoplastic rat liver lesions 56
Regulation of Amphiregulin Gene Expression by β-Catenin Signaling in Human Hepatocellular Carcinoma Cells: A Novel Crosstalk between FGF19 and the EGFR System 56
Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: a long-term study. 55
Prognostic markers and putative therapeutic targets for hepatocellular carcinoma. 55
c-myc amplification in pre-malignant and malignant lesions induced in rat liver by the resistant hepatocyte model 55
Identification and chromosome mapping of loci predisposing to colorectal cancer that control Wnt/b-catenin pathway and progression of early lesions in the rat 54
Dual-Specific Phosphatase 1 Ubiquitination in Extracellular Signal-Regulated Kinase-Mediated control of Grawth in Human Hepatocellular Carcinoma 54
Phenotypic reversion of rat neoplastic liver nodules is under genetic control 53
Amplification of c-myc oncogene in preneoplastic e neoplastic lesions induced in rat liver by the resistant hepatocyte protocol 53
SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis 53
Reversal by ribo- and deoxyribonucleosides of dehydroepiandrosterone-induced inhibition of enzyme altered foci in the liver of rats subjected to the initiation--selection process of experimental carcinogenesis. 53
Inhibition by dehydroepiandrosterone of growth and progression of persistent liver nodules in experimental rat liver carcinogenesis 52
Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis 52
The mTORC2-Akt1 Cascade Is Crucial for c-Myc to Promote Hepatocarcinogenesis in Mice and Humans 52
Benzo(a)pyrene metabolism by lymphocytes from normal individuals and individuals carrying the Mediterranean variant of glucose-6-phosphate dehydrogenase. 52
. Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid. 52
Inhibition by dehydroepiandrosterone of liver preneoplastic foci formation in rats after initiation-selection in experimental carcinogenesis. 52
Long-term dehydroepiandrosterone and 16alfa-fluoro-5-androsten-17-one administration enhances DNA synthesis and induces expression of c-fos and c-Ha-ras in a selected population of preneoplastic lesions in liver of diethylnitrosamine-initiated rats 52
Protooncogene methylation and expression in regenerating liver and preneoplastic liver nodules induced in the rat by diethylnitrosamine: effect of variations of S-adenosylmethionine:S-adenosylhomocysteine ratio. 51
Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesis 51
Persistent chemopreventive effect of S-adenosyl-L-methionine on the development of liver putative preneoplastic lesions induced by thiobenzamide in diethylnitrosamine-initiated rats 51
Differential effects of dehydroepiandrosterone and deoxyribonucleosides on DNA synthesis and de novo cholesterogenesis in hepatocarcinogenesis in rats. 51
Expression of N-acetylglucosaminyltransferase III in hepatic nodules generated by different models of rat liver carcinogenesis. 50
Chemopreventive N-(4-hidroxyphenyl)retinamide targets NF-kB and Mat1A genes in early stages of rat liver carcinogenesis. 50
Epigenetics of liver cancer progression: Role of transcriptional and post-transcriptional regulation of methionine adenosyltransferases in liver cancer progression. 50
Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease 50
Construction of a phylogenetic tree for inbred strains of rat by arbitrarily primed polymerase chain reaction (AP-PCR). 50
Variations of ornithine decarboxylase activity and S-adenosyl-L-methionine and 5'-methylthioadenosine contents during the development of diethylnitrosamine-induced liver hyperplastic nodules and hepatocellular carcinoma. 50
Effect of the variations of S-adenosyl-L-methionine liver content on fat accumulation and ethanol metabolism in ethanol-intoxicated rats 49
Role of Dehydroepiandrosterone in Experimental and Human Carcinogenesis 49
Combined CDK4/6 and pan-mTOR inhibition is synergistic against intrahepatic cholangiocarcinoma 49
Alterations of ornithine decarboxylase gene during the progression of rat liver carcinogenesis. 49
New putative prognostic markers and therapeutic targets for the molecular approach to treatment of hepatocellular carcinoma 49
Mapping a sex-hormone sensitive gene determining female resistance to liver carcinogenesis in a congenic F344 BN-Hcs4 rat. 49
An infernal cross-talk between oncogenic β-catenin and c-Met in hepatocellular carcinoma: Evidence from mouse modeling 48
S-Adenosylmethionine Regulates Apurinic/Apyrimidinic Endonuclease 1 Stability: Implication in Hepatocarcinogenesis 47
Multifocal hepatocellular carcinoma: intrahepatic metastasis or multicentric carcinogenesis? 47
Correlation between S-adenosyl-L-methionine content and production of c-myc, c-Ha-ras, and c-Ki-ras mRNA transcripts in the early stages of rat liver carcinogenesis. 47
Role of transcriptional and postttranscriptional regulation of methionine adenosyltransferases in liver cancer progression. 47
Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value 46
Comparative effects of L-methionine, S-adenosyl-L-methionine and 5'-methylthioadenosine on the growth of preneoplastic lesions and DNA methylation in rat liver during the early stages of hepatocarcinogenesis 46
The post-transcriptional dysregulation of methionine adenosyl-transferases is crucial for the progression of rat and human liver cancer. 47° Annual Meeting of the European Association for Study of the Liver (EASL) Aprile 18-22, 2012 46
Ruolo di HSP90, CDC37 e CRM1 come modulatori dell’attività di p16 INK4A nella cancerogenesi epatica di ratto e nel carcinoma epatocellulare umano 46
Transferrin and transferrin receptor gene expression in benign and malignant rat liver lesions. 46
An expression signature of phenotipic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis 46
Genetic alterations in liver carcinogenesis: implication for new preventive therapeutic strategies 45
Deregulation of signalling pathways in prognostic subtypes of hepatocellular carcinoma: Novel insights from interspecies comparison 45
Reversal by 5-azacytidine of the S-adenosyl-L-methionine-induced inhibition of the development of putative preneoplastic foci in rat liver carcinogenesis 45
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice 45
Sulfatase 1: A new Jekyll and Hyde in hepatocellular carcinoma? 45
Ras-driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control 44
the role of S-adenosylmethionine in the regulation of glutathione pool and acetaldehyde production in acute ethanolintoxication 44
Laboratory test alterations in patients with COVID-19 and non COVID-19 interstitial pneumonia: a preliminary report 44
SNAI1 promotes the cholangiocellular phenotype, but not epithelial-mesenchymal transition, in a murine hepatocellular carcinoma model 44
Focal loss of long non-coding RNA-PRAL, as determinant of cell function and phenotype of hepatocellular carcinoma 44
The role of phosphatidylethanolamine methylation in the synthesis of phosphatidylcholinein acute ethanol intoxication. 44
Polygenic control of hepatocarcinogenesis in Copenhagen x F344 rats 43
Instabilità genomica nel carcinoma mammario 43
DNA-PKcs: A promising therapeutic target in human hepatocellular carcinoma? 43
Early stimulation of polyamine biosynthesis during promotion by phenobarbital of diethylnitrosamine-induced rat liver carcinogenesis. The effects of variations of the S-adenosyl-L-methionine cellular pooL 43
Inhibition by ethanol of rat liver plasma membrane (Na+,K+)ATPase: protective effect of S-adenosyl-L-methionine, L-methionine, and N-acetylcysteine. 43
Stearoyl-CoA desaturase 1 (Scd1) gene overexpression is associated with genetic predisposition to hepatocarcinogenesis in mice and rats 43
Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype 43
Genetic Control of Resistance to Hepatocarcinogenesis by the Mouse Hpcr3 Locus 42
Modulatory mechanisms of chemical carcinogenesis: the role of the NADPH pool in the benzo(a)pyrene activation. 42
TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma 42
Identification and characterization of a cDNA clone for a gene overexpressed in preneoplastic e neoplastic lesions in rat liver 42
Totale 5.342
Categoria #
all - tutte 30.304
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.304

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.456 342 20 103 9 126 167 303 33 146 55 142 10
2020/20211.249 133 6 188 13 135 72 143 8 188 180 148 35
2021/2022784 116 8 6 11 24 33 45 46 73 42 84 296
2022/20231.658 179 147 43 293 152 279 0 189 278 6 57 35
2023/2024390 89 27 13 16 54 15 0 14 0 3 53 106
2024/202525 25 0 0 0 0 0 0 0 0 0 0 0
Totale 6.506